Home » Topics » BioWorld Science

BioWorld Science
RSS

Nilotinib improves biomarkers of Parkinson's disease in phase II study

Aug. 27, 2018

Unexpected asthma mechanism changes targeting calculus

Aug. 27, 2018

Brain-on-three-chips includes BBB

Aug. 27, 2018

Parkin, PINK keep inflammation pout of the red zone

Aug. 27, 2018

Kinase interplay prevents ALS

Aug. 27, 2018

FDA approves cobas EGFR Mutation Test v2 as companion diagnostic test with Iressa

Aug. 24, 2018

bluebird bio and Gritstone Oncology establish cancer cell therapy collaboration

Aug. 24, 2018

FDA approves Inveltys for post-operative inflammation and pain

Aug. 24, 2018

Telix submits CTA to begin phase III trial in Europe with TLX-250 for renal cancer imaging

Aug. 24, 2018

FDA approves Diacomit for seizures associated with Dravet syndrome

Aug. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...